Hairy Cell Leukemia

Hairy cell leukemia is a cancer of a type of white blood cell that originates in the bone marrow, the soft spongy tissue located in the center of bones throughout the body. It is a rare, slow-growing cancer that affects white blood cells called B lymphocytes. Healthy B lymphocytes make antibodies—proteins that fight infection in the body.

In people with hairy cell leukemia, the bone marrow produces abnormal B lymphocytes. These cells have tiny hairlike projections, giving the cancer its name.

Treatment for Hairy Cell Leukemia

We provide ongoing, compassionate care and monitoring for people with hairy cell leukemia. Our specialists use sophisticated tests to diagnose this chronic disease and create a personalized treatment plan to manage it. Treatment for hairy cell leukemia may include surgery as well as medication. Our team of oncologists, nurses, physical therapists, psychologists, and social workers can help enhance your wellbeing throughout treatment and recovery.

Clinical Trials and Research Studies

Phase 5

A Phase 1/2 Open-label Study Investigating the Safety Tolerability and Efficacy of ASP7517 in subjects with Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)

Learn More

Phase 2

A PHASE IB-II STUDY OF HIGH-DOSE POST-TRANSPLANT CYCLOPHOSPHAMIDE BORTEZOMIB AND ABATACEPT FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE (GVHD) FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)

Learn More

Phase 2

Single-arm open label phase II study of MBG453 (sabatolimab) added to FDA approved Hypomethylating agents of investigator s choice (IV/SC/Oral) for patients with intermediate high or very high risk myelodysplastic syndrome (MDS) as per IPSS-R criteria (US multi-center) (STIMULUS MDS-US)

Learn More

Phase 3

A Phase 3 Randomized Multicenter Double-Blind Placebo-Controlled Efficacy and Safety Study of Birtamimab Plus Standard of Care vs. Placebo Plus Standard of Care in Mayo Stage IV Subjects with Light Chain (AL) Amyloidosis

Learn More